January is designated as Cervical Cancer Awareness Month globally, a crucial period to highlight the preventability of this disease, often referred to as a "silent killer" due to its asymptomatic early stages. The primary strategies for combating cervical cancer are Human Papillomavirus (HPV) vaccination and regular screening. HPV vaccines are highly effective in preventing infections with high-risk HPV types, which cause the majority of cervical cancers, particularly when administered to young individuals before sexual activity. Evidence, including new Cochrane reviews, strongly confirms that HPV vaccination significantly reduces the risk of developing cervical cancer and pre-cancerous changes, with girls vaccinated before age 16 being 80% less likely to develop cervical cancer. Alongside vaccination, consistent cervical cancer screening, including Pap tests and HPV DNA testing, plays a pivotal role. These screenings enable the early detection of precancerous lesions, allowing for timely treatment before they progress to invasive cancer. The World Health Organization (WHO) recommends screening women with a high-performance test every 5–10 years starting at age 30, with a global strategy aiming for 70% of women screened by age 35 and again by 45 by 2030. For India, cervical cancer remains a significant public health challenge, with experts noting that a woman dies every eight minutes from the disease. Despite being largely preventable, awareness and access to effective screening programs and HPV vaccination have historically been low in the country. Government initiatives and health experts stress the importance of increasing public awareness, affordability, and accessibility of both vaccination and screening programs to reduce India's cervical cancer burden. Timely intervention through these combined preventive measures offers a powerful pathway to saving lives and moving towards the global elimination of cervical cancer.